ICVS researcher Nuno Dinis Alves was granted with the Career Support Grant by the International Society for Neurochemistry. 

ICVS took part in the second edition of the Alto Minho Science Fest 2026, held from March 12 to 15 in Arcos de Valdevez, bringing science closer to the community through a dynamic programme of interactive activities focused on the brain, health, and well-being.

ICVS researcher Agostinho Carvalho is co-author of a study recently published in Nature that explains why some people are more likely to develop mucormycosis, a rare and often deadly fungal infection also known as “black fungus.” This infection gained global attention following its surge in India during the second wave of COVID-19.

ICVS researcher Sara Calafate has been awarded €250,000 to develop a project investigating how sleep contributes to brain homeostasis/balance and memory organization.

ICVS researcher Belém Sampaio-Marques has been recognized in the iProof – Technology Acceleration Programme, promoted by TecMinho, for her project “Brain-targeting liposomal delivery of MSCs-derived secretome for Parkinson’s Disease treatment” (LIPOSEC4PD).

Researchers from ICVS, in collaboration with i3S, University of Coimbra and international partners, have unveiled a promising new strategy for the treatment of Machado–Joseph disease, also known as Spinocerebellar Ataxia Type 3 (SCA3). The study, published in the prestigious journal Advanced Science, focuses on preventing the aggregation of mutant ataxin-3 protein, the molecular cause of this rare, inherited neurodegenerative disease, for which there is currently no cure.